Our Readers Respond
No drugs down the drain In approximately 2008 I wrote my final paper in BSN community health on this environmental issue. I am delighted…
Web Exclusives
FDA announces recall of drug products from Med Prep Consulting
On March 18, the U.S. Food and Drug Administration (FDA) announced a voluntary nationwide recall of all lots of all products produced by Med…
FDA encourages prescribers to seek education on prescribing opioid pain meds
On March 1, 2013, the U.S. Food and Drug Administration (FDA) announced that it is joining health professional organizations in encouraging prescribers to seek…
Study: Shortages of cancer drugs associated with medication errors and higher
A study in the American Journal of Health-System Pharmacy reports a survey of oncology pharmacists in the United States found that shortages of oncology…
Study: Fewer work hours for medical residents could have unintended consequences
A study in JAMA Internal Medicine comparing schedules of first-year residents found that fewer work hours increased the number of patient handoffs (affecting continuity…
Hospital volume associated with better survival in patients with head and neck cancer
“Hospital volume is associated with survival but not multimodality therapy in Medicare patients with advanced head and neck cancer,” published in Cancer, found that…
RAC audits continue to increase
A new report from the American Hospital Association says recovery and contractor (RAC) audits continue to increase. Of the 1,233 hospitals that responded to…
Despite efforts C. difficile remains significant problem in hospitals
According to “2013 Clostridium difficile infection (CDI) Pace of Progress Survey: Results of an online poll of infection preventionists,” 70% of respondents have adopted…
FDA approves new silicone breast implant
On Feb. 20, 2013, the U.S. Food and Drug Administration (FDA) approved the Natrelle 410 Highly Cohesive Anatomically Shaped Silicone-Gel Filled Breast Implant for…
FDA approves Pomalyst for advanced multiple myeloma
On Feb. 8, 2013, the U.S. Food and Drug Administration (FDA) approved Pomalyst (pomalidomide) to treat patients with multiple myeloma whose disease has progressed…
FDA approves Osphena for postmenopausal women with dyspareunia
On Feb. 26, 2013, the U.S. Food and Drug Administration (FDA) approved Osphena (ospemifene) to treat women with moderate to severe dyspareunia (pain during…
FDA approves first retinal implant for adults with advanced retinitis pigmentosa
On Feb. 20, 2013, the U.S. Food and Drug Administration (FDA) approved the Argus II Retinal Prosthesis System, the first implanted device to treat…
Our Readers Respond
No drugs down the drain In approximately 2008 I wrote my final paper in BSN community health on this environmental issue. I…
FDA announces recall of drug products from Med Prep Consulting
On March 18, the U.S. Food and Drug Administration (FDA) announced a voluntary nationwide recall of all lots of all products produced…
FDA encourages prescribers to seek education on prescribing opioid pain meds
On March 1, 2013, the U.S. Food and Drug Administration (FDA) announced that it is joining health professional organizations in encouraging prescribers…
Study: Shortages of cancer drugs associated with medication errors and higher
A study in the American Journal of Health-System Pharmacy reports a survey of oncology pharmacists in the United States found that shortages…
Study: Fewer work hours for medical residents could have unintended consequences
A study in JAMA Internal Medicine comparing schedules of first-year residents found that fewer work hours increased the number of patient handoffs…
Hospital volume associated with better survival in patients with head and neck cancer
“Hospital volume is associated with survival but not multimodality therapy in Medicare patients with advanced head and neck cancer,” published in Cancer,…
RAC audits continue to increase
A new report from the American Hospital Association says recovery and contractor (RAC) audits continue to increase. Of the 1,233 hospitals that…
Despite efforts C. difficile remains significant problem in hospitals
According to “2013 Clostridium difficile infection (CDI) Pace of Progress Survey: Results of an online poll of infection preventionists,” 70% of respondents…
FDA approves new silicone breast implant
On Feb. 20, 2013, the U.S. Food and Drug Administration (FDA) approved the Natrelle 410 Highly Cohesive Anatomically Shaped Silicone-Gel Filled Breast…
FDA approves Pomalyst for advanced multiple myeloma
On Feb. 8, 2013, the U.S. Food and Drug Administration (FDA) approved Pomalyst (pomalidomide) to treat patients with multiple myeloma whose disease…
FDA approves Osphena for postmenopausal women with dyspareunia
On Feb. 26, 2013, the U.S. Food and Drug Administration (FDA) approved Osphena (ospemifene) to treat women with moderate to severe dyspareunia…
FDA approves first retinal implant for adults with advanced retinitis pigmentosa
On Feb. 20, 2013, the U.S. Food and Drug Administration (FDA) approved the Argus II Retinal Prosthesis System, the first implanted device…
Poll
Preferred way to get content
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.
NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.